Hansoh Pharmaceutical Group Company Limited: all 186 studies

Page 1 of 2. Open to participants first (116), then studies with results posted, then the rest; newest registration first within each.

• A Phase I Study of HS-20093 in Combination With ZG006 With or Without Adebrelimab in Patients With ES-SCLCNot yet recruitingNCT07892625Phase 1
• A Study of HS-10382 Versus Investigator-selected TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPNot yet recruitingNCT07885293Phase 3
• An Open-label Study of HS-20137 in Participants With Moderate-to-Severe Plaque PsoriasisRecruitingNCT07879885Phase 2
• A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of HS-10506RecruitingNCT07844967Phase 1
• A Pharmacokinetic Study of HS-10504 in Participants With Hepatic Impairment and Normal Hepatic Function.Not yet recruitingNCT07836504Phase 1
• A Study of HS-20197 in Participants With Advanced Solid TumorsNot yet recruitingNCT07834359Phase 1
• A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic AlterationsRecruitingNCT07824882Phase 2
• A Study Evaluating HS-10370 Plus Platinum-based Doublet Chemotherapy With or Without Adebrelimab vs. Tislelizumab Plus Chemotherapy as First-Line Therapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerNot yet recruitingNCT07822542Phase 3
• Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian CancerNot yet recruitingNCT07821606Phase 3
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10582 in Healthy Subjects and Subjects With Mildly Elevated LDL-C LevelsNot yet recruitingNCT07777003Phase 1
• HS-20117-2 Injection in Patients With Advanced Solid TumorsRecruitingNCT07775703Phase 1
• A Phase I Clinical Trial to Evaluate Pharmacokinetics of HS-10504Not yet recruitingNCT07770217Phase 1
• A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque PsoriasisNot yet recruitingNCT07765628Phase 2
• A Mass Balance Study of [14C]HS-10504Not yet recruitingNCT07764705Phase 1
• A Phase I Clinical Trial to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10504Not yet recruitingNCT07764692Phase 1
• A Study to Evaluate the Long-term Safety of HS-10380 in Patients With SchizophreniaNot yet recruitingNCT07759869Phase 3
• Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLCNot yet recruitingNCT07754123Phase 3
• A Phase I Study of Single and Multiple Doses of HS-20136-2 Injection in Healthy or Obese ParticipantsNot yet recruitingNCT07716241Phase 1
• An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung CancerNot yet recruitingNCT07685041Phase 1
• A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia DisorderNot yet recruitingNCT07677384Phase 3
• PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLCRecruitingNCT07645222Phase 1
• A Study of HS-20093 in Patients With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)Not yet recruitingNCT07621601Phase 3
• Phase 1 Study of HS-10541 as Monotherapy or in Combination With Other Anti-cancer Therapies in Patients With KRAS G12C Mutation Advanced Solid Tumors.Not yet recruitingNCT07615413Phase 1
• A Phase I Single and Multiple Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of HS-10522 in Healthy Chinese Participants and Chinese Participants With Mild HypertensionNot yet recruitingNCT07609875Phase 1
• A Study of HS-10506 in Chinese Patients With Insomnia DisorderNot yet recruitingNCT07587385Phase 3
• A Study of HS-10587 in Patients With Advanced Solid TumorsNot yet recruitingNCT07567859Phase 1
• A Study of the Effect and Safety of HS-10390 in the Treatment of Participants With Chronic Kidney DiseaseNot yet recruitingNCT07555054Phase 2
• A Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10506 in Healthy Chinese Adult ParticipantsNot yet recruitingNCT07535970Phase 1
• Phase 1 Study of HS-20152 in Healthy ParticipantsNot yet recruitingNCT07503015Phase 1
• A Study of HS-20136-2 in Healthy ParticipantsNot yet recruitingNCT07483437Phase 1
• Efficacy and Safety Study of HS-10542 for IgA NephropathyNot yet recruitingNCT07474636Phase 2
• Study of Safety and Efficacy of HS-10542 in Patients With Paroxysmal Nocturnal HemoglobinuriaRecruitingNCT07470762Phase 1/2
• A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical CystectomyRecruitingNCT07468851Phase 1/2
• A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic AlterationsNot yet recruitingNCT07464327Phase 3
• HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction AdenocarcinomaRecruitingNCT07462923Phase 1
• A Phase Ib Study of HS-10504 Combined Therapy in NSCLCNot yet recruitingNCT07414953Phase 1
• A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.RecruitingNCT07283367Phase 1/2
• Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid TumorsRecruitingNCT07186452Phase 1
• A Phase 3 Study of HS-20094 in Patients With T2DMNot yet recruitingNCT07156539Phase 3
• A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise AloneNot yet recruitingNCT07156500Phase 3
• A Study of Aumolertinib in European Participants With Non-Small Cell Lung CancerRecruitingNCT07130916Phase 1
• Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate CancerRecruitingNCT07115446Phase 1
• Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell CarcinomaRecruitingNCT07097935Phase 1/2
• Phase 1 Study of HS-20093 Combinations in Patients With Extensive Stage Small Cell Lung CancerNot yet recruitingNCT07063407Phase 1
• A Study of HS-20094 in Overweight or Obese ParticipantsRecruitingNCT07057674Phase 1
• HS-10542 Study in Healthy ParticipantsRecruitingNCT07040046Phase 1
• Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118RecruitingNCT07033234Phase 1
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10510 in Healthy SubjectsNot yet recruitingNCT07001787Phase 1
• A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid TumorsNot yet recruitingNCT06963502Phase 1
• A Study of HS-10529 in KRAS G12D Patients With Advanced Solid TumorsNot yet recruitingNCT06963398Phase 1
• A Phase I Study of HS-20108 in Participants With Advanced Solid TumorsRecruitingNCT06936735Phase 1
• A Study of HS-20122 in Patients With Advanced Solid TumorsRecruitingNCT06927570Phase 1
• A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque PsoriasisNot yet recruitingNCT06926582Phase 2
• A Study Evaluating the Effect of Aumolertinib on the Pharmacokinetics of Midazolam in Patients With NSCLCRecruitingNCT06926413Phase 1
• A Study of HS-20110 in Participants With Advanced Solid TumorsRecruitingNCT06892379Phase 1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria.Not yet recruitingNCT06864507Phase 1/2
• HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian CancerRecruitingNCT06855069Phase 3
• Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118RecruitingNCT06846710Phase 1
• A Study of HS-20137 in Participants with Moderate-to-severe Plaque PsoriasisNot yet recruitingNCT06844799Phase 3
• ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal CancerRecruitingNCT06825624Phase 1
• Pharmacokinetic Study of HS-10365 Capsule in Subjects with Hepatic Impairment and Normal Hepatic FunctionNot yet recruitingNCT06823258Phase 1
• Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic FunctionNot yet recruitingNCT06823245Phase 1
• HS-10502 Combination Treatment in Patients With Advanced Solid TumorsRecruitingNCT06769425Phase 1
• A Study of HS-20124 in Patients with Advanced Solid TumorsRecruitingNCT06763159Phase 1
• ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma.Not yet recruitingNCT06699576Phase 1
• A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque PsoriasisNot yet recruitingNCT06672393Phase 3
• A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA NephropathyNot yet recruitingNCT06635772Phase 2
• Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid TumorsRecruitingNCT06621563Phase 1
• A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic SyndromesNot yet recruitingNCT06594965Phase 2
• A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid TumorsNot yet recruitingNCT06594874Phase 1
• A Study Evaluating Food Effect on Pharmacokinetics of HS-10518Not yet recruitingNCT06554548Phase 1
• A Study of HS-10516 in Patients With VHL Syndrome Associated TumorsRecruitingNCT06553339Phase 1
• Study of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)Not yet recruitingNCT06530810Phase 1
• A Study of HS-20093 vs Active Surveillance in Limited-Stage Small Cell Lung CancerNot yet recruitingNCT06526624Phase 3
• A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)RecruitingNCT06461156Phase 1
• A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung CancerRecruitingNCT06417008Phase 2/3
• A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal WomenNot yet recruitingNCT06393673Phase 2
• Phase 1 Study in Healthy Participants and Participants With Kidney DysfunctionNot yet recruitingNCT06383897Phase 1
• A Study of HS-10501 Tablets in Healthy SubjectsRecruitingNCT06359600Phase 1
• HS-20089 Combination Treatment in Subjects With Advanced Solid TumorsRecruitingNCT06336707Phase 1
• ARTEMIS-101: A Study of HS-20093 Combinations in Patients With Advanced Solid TumorsRecruitingNCT06332170Phase 1
• The Phase I Study of HS-10509 in Chinese Adult SubjectsNot yet recruitingNCT06301074Phase 1
• Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia DisorderNot yet recruitingNCT06279286Phase 1/2
• A Study of HS-10383 in Chinese Adult Subjects With Refractory or Unexplained Chronic Cough (RUCC)Not yet recruitingNCT06246565Phase 2
• A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum DisordersNot yet recruitingNCT06212245Phase 4
• A Trial of HS-10511 in Healthy SubjectsNot yet recruitingNCT06210607Phase 1
• Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic ArthritisRecruitingNCT06176508Phase 2
• A Study of HS-10365 in Patients With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung CancerRecruitingNCT06147570Phase 2
• Study of HS-20105 for Injection in Patients With Advanced Solid Tumors.Not yet recruitingNCT06144723Phase 1/2
• Study of HS-10384 in Participants of Chinese Postmenopausal WomenRecruitingNCT06122181Phase 1
• A Study of HS-10518 in Healthy Female ParticipantsNot yet recruitingNCT06118827Phase 1
• HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid TumorsRecruitingNCT06112704Phase 2
• A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI TherapyNot yet recruitingNCT06110663Phase 3
• A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque PsoriasisRecruitingNCT06077331Phase 2
• A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell CarcinomaNot yet recruitingNCT06049030Phase 1
• HS-20089 in Patients With Ovarian Cancer and Endometrial CancerRecruitingNCT06014190Phase 2
• ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid TumorsRecruitingNCT06007729Phase 2
• ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid TumorsRecruitingNCT06001255Phase 2
• Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With SchizophreniaNot yet recruitingNCT05964790Phase 1/2
• Phase 1a Study in Healthy ParticipantsNot yet recruitingNCT05953506Phase 1

← Hansoh Pharmaceutical Group Company Limited overview and focus areas